The Edge Medical® single-port laparoscopic surgical robot has successfully completed its first overseas clinical procedures at the National Medical Institute of the Ministry of Interior of Poland (PIM MSWiA) in Warsaw. World-renowned urologic surgeon Professor Simone Crivellaro and Dr. Paweł Wisz performed three consecutive high-complexity urological procedures through a single incision of approximately 3 centimeters — fully demonstrating the technical reliability and clinical value of the Edge Medical® single-port robotic system in a real-world international healthcare setting.

This successful debut marks a defining milestone for China's first independently developed single-arm single-port robot — a critical transition from regulatory clearance to clinical validation — firmly placing China's coordinates on the global frontier of single-port robotic surgery.

Three Consecutive Victories on Debut

China's First Single-Arm Single-Port Robot Makes Its European Clinical Debut

The procedures were performed at PIM MSWiA — a national-level Polish medical institution — led by Professor Simone Crivellaro, Director of Minimally Invasive Urology at the University of Illinois Chicago and one of the world's foremost urological surgeons, alongside Dr. Paweł Wisz, Director of the Robotics Center at PIM MSWiA. All three cases involved high-complexity urological procedures in confined anatomical spaces, performed in the supine position — an approach that significantly reduces intraoperative pressure on the thoracic cavity compared to conventional lateral positioning.

All procedures were completed through a single incision of approximately 3 centimeters, through which the endoscope and all instruments were introduced — achieving true single-port access. For patients, this translates into minimized tissue trauma and accelerated recovery, representing the continued evolution of minimally invasive surgery.

One of the cases — a retroperitoneal partial nephrectomy — involved a patient with two solid tumors in a single kidney, multiple cysts at the upper pole, and a 5 cm mass at the renal upper pole. Facing this anatomical challenge, the Edge Medical® single-port robotic system demonstrated several core technical capabilities.

The procedure was performed via a transabdominal single-port approach in the supine position. Compared to conventional multiport lateral approaches, the supine position provided more organized anatomical planes and clearer vascular exposure. Professor Crivellaro navigated the Edge Medical® single-port robot through the dense neurovascular structures at the renal hilum — including major blood vessels, lymphatics, and the collecting system — with exceptional precision, achieving meticulous dissection and plane separation while fully preserving the renal artery, renal vein, and normal collecting system architecture, and precisely exposing the multifocal tumors at the upper and mid-pole.

During the procedure, the system's "repositioning" function  enabled the surgeon to swiftly shift the operative target — seamlessly transitioning from the upper pole to the mid-pole of the kidney. This capability significantly enhanced both precision and safety for the resection of multifocal, spatially distributed renal tumors, while maintaining stable, unobstructed instrument operation and a consistently focused surgical field.

The system's multimodal picture-in-picture function enabled real-time ultrasound imaging to be integrated directly into the primary surgical field — allowing the surgeon to simultaneously view the operative site and the ultrasound display, optimizing tumor margin localization while maximizing preservation of healthy renal tissue.

The procedure progressed with fluid efficiency — precise anatomical planes, reliable hemostasis, and less than 20 mL of blood loss — achieving complete oncological resection, intact preservation of critical vascular structures, maximum renal function protection, and a minimally invasive outcome with excellent cosmesis.

 Dual-Console Real-Time Surgical Mentorship

 Seamless Transition from Multi-Port to Single-Port

A defining highlight of this session was the full demonstration of Edge Medical®'s dual-console technology.

In the first two radical prostatectomy cases, Professor Crivellaro served as the guiding surgeon, with both surgeons operating from their respective consoles simultaneously — enabling real-time intraoperative skill transfer and collaborative control.

This was Dr. Wisz's first single-port robotic procedure. Drawing on his extensive prior experience with the Edge Medical® multi-port platform, and guided in real time by Professor Crivellaro from the second console, Dr. Wisz rapidly achieved independent proficiency and completed the critical steps of the single-port robotic radical prostatectomy on his own. This powerfully demonstrated one of the Edge Medical® ecosystem's unique advantages: the single-port and multi-port platforms share the same console, enabling surgical teams to transition seamlessly between modalities — with an exceptionally short learning curve and immediate clinical readiness.

This feature substantially reduces hospital training costs when adopting new robotic technologies, and establishes a strong technical foundation for the large-scale clinical expansion of single-port robotic surgery.

Live Observation Across Europe and China

 Global Broadcast via Premier Platform

The procedures drew live observers from medical teams across Europe and China. The session was simultaneously broadcast on ORSI Academy — one of the world's leading robotic surgery training centers — attracting surgeons from multiple countries to tune in and learn in real time.

China's Edge Medical® single-port robot helped make Poland, once again, an important stage for the first deployment of Europe's newest surgical technologies.

As a national-level Polish medical research institution, PIM MSWiA expressed high praise for this clinical application — noting that the procedure demonstrated how modern surgical technology is transforming patient care and redefining how medical teams operate, and that it carries significant value for enhancing surgical team capabilities and training the next generation of robotic surgeons.

Placing China's Mark on the Frontier

 From "Global Market Entry" to "Globally Validated Technology"

Single-port robotics represents the leading edge of minimally invasive surgical innovation — a field characterized by immense technical barriers, and one that the world's foremost surgical robot companies have long prioritized.

The Edge Medical® single-port surgical robot is the first single-arm, single-port surgical robot approved in China, and received CE certification from the European Union in October 2025. It delivers a portfolio of globally leading capabilities: a highly integrated design achieving smaller incisions, exceptional dexterity, an outstanding master-slave control experience, ultra-low latency, and immersive 3D HD imaging. Compared to international counterparts, the system is smaller and lighter, requires less surgical space, and provides a greater depth of reach for lesion access. The next-generation SuperArm instrument series is purpose-engineered for working in confined anatomical spaces, delivering superior flexibility and load capacity — enabling outstanding performance across both conventional approaches and natural orifice approaches.

The system has been deployed across gynecology, urology, general surgery, thoracic surgery, head and neck surgery, and breast surgery, with over 3,000 clinical procedures completed — demonstrating broad adaptability and consistently excellent clinical performance.

The successful completion of Edge Medical®'s first overseas clinical procedures marks a pivotal transition from regulatory clearance to clinical validation — placing China firmly at the cutting edge of global single-port robotic surgery. It stands as a defining milestone in the journey of China's homegrown surgical robots from entering global markets to earning global clinical trust.

Moving forward, Edge Medical® will continue to place clinical value at the center of everything it does — driven by technological innovation — to bring China's original minimally invasive surgical technologies to patients around the world.